Integration of an Expression Platform in the SELEX Cycle to Select DNA Aptamer Binding to a Disease Biomarker

[Image: see text] Aptamers can be developed for biosensors, diagnostic tools, and therapeutic reagents. These applications usually require a fusion of aptamers and expression platforms. However, the fusion process is usually time-consuming and laborious. In this study, we integrated the deoxyribozym...

Descripción completa

Detalles Bibliográficos
Autores principales: Ao, Yaqi, Duan, Anqi, Chen, Binfen, Yu, Xinmei, Wu, Yaoyao, Zhang, Xiaojun, Li, Sanshu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8973154/
https://www.ncbi.nlm.nih.gov/pubmed/35382297
http://dx.doi.org/10.1021/acsomega.2c00769

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8973154/
https://www.ncbi.nlm.nih.gov/pubmed/35382297
http://dx.doi.org/10.1021/acsomega.2c00769

Ejemplares similares